Agenus Inc (AGEN)

Agenus announces reverse stock split of common stock - MSN

MSN

Agenus sets FDA meeting for cancer therapy path - Investing.com Canada

Investing.com Canada

Agenus (AGEN) Stock Sinks As Market Gains: What You Should Know - Yahoo Singapore News

Yahoo Singapore News

Agenus sets FDA meeting for cancer therapy path - Investing.com

Investing.com

Agenus sets FDA meeting for cancer therapy path By Investing.com - Investing.com UK

Investing.com UK

FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory ... - Business Wire

Business Wire

Therapeutic Vaccines Market Drivers, Size, Biggest Share, - openPR

openPR

Therapeutic Vaccines Market Drivers, Size, Biggest Share, Growth Opportunities 2024-2032 by Pfizer, Transgene ... - openPR

openPR

Agenus Inc. (NASDAQ:AGEN) Short Interest Update - Defense World

Defense World

Agenus Inc. (NASDAQ:AGEN) Short Interest Update - MarketBeat

MarketBeat

Q2 2024 Earnings Forecast for Agenus Inc. (NASDAQ:AGEN) Issued By B. Riley - MarketBeat

MarketBeat

Agenus (AGEN) Stock Sinks As Market Gains: What You Should Know - Yahoo Singapore News

Yahoo Singapore News

Agenus Inc. (NASDAQ:AGEN) to Post Q2 2024 Earnings of ($0.02) Per Share, B. Riley Forecasts - Defense World

Defense World

Q2 2024 EPS Estimates for Agenus Inc. Raised by Analyst (NASDAQ:AGEN) - Defense World

Defense World

Ahead of the Bell: Agenus shares tumble - Yahoo New Zealand News

Yahoo New Zealand News

Q2 2024 EPS Estimates for Agenus Inc. Lifted by William Blair (NASDAQ:AGEN) - Defense World

Defense World

Q2 2024 Earnings Forecast for Agenus Inc. Issued By HC Wainwright (NASDAQ:AGEN) - MarketBeat

MarketBeat

Q2 2024 Earnings Forecast for Agenus Inc. Issued By HC Wainwright (NASDAQ:AGEN) - MarketBeat

MarketBeat

Agenus' (AGEN) Q1 Loss Wider than Expected, Shares Down - Yahoo Movies UK

Yahoo Movies UK

Analysts Have Lowered Expectations For Agenus Inc. (NASDAQ:AGEN) After Its Latest Results - Simply Wall St

Simply Wall St

Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates

Zacks Investment Research

Agenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Agenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Agenus Inc (AGEN) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and Financial Updates - GuruFocus.com

GuruFocus.com

Agenus First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Yahoo Finance

News Flash: Analysts Just Made A Substantial Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Forecasts - Yahoo News UK

Yahoo News UK

Agenus: Q1 Earnings Snapshot - Houston Chronicle

Houston Chronicle

Agenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Agenus Reports First Quarter 2024 Results - citybiz

citybiz

Ligand invests $75 million in Agenus cancer drug development - Investing.com

Investing.com

Agenus (AGEN) Q1 2024 Earnings Call Transcript

The Motley Fool

Agenus' (AGEN) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

MarketBeat

Agenus: Q1 Earnings Snapshot - The Washington Post

The Washington Post

Agenus (AGEN) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research

Agenus Inc (AGEN) Q1 2024 Earnings: Misses Revenue and EPS Estimates Amid Strategic Developments - Yahoo Finance

Yahoo Finance

Agenus Reports First Quarter 2024 Results - br.ADVFN.com

br.ADVFN.com

Agenus Secures Strategic Finance Deal with Ligand - TipRanks.com - TipRanks

TipRanks

Agenus Reports First Quarter 2024 Results - Business Wire

Business Wire

Agenus' (AGEN) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

MarketBeat

Analysts Estimate Agenus (AGEN) to Report a Decline in Earnings: What to Look Out for - Yahoo Singapore News

Yahoo Singapore News

Agenus (AGEN) to Release Earnings on Tuesday - Defense World

Defense World

Agenus (AGEN) to Release Earnings on Tuesday - Defense World

Defense World

Agenus (NASDAQ:AGEN) adds US$89m to market cap in the past 7 days, though investors from five years ago are still down 78% - Simply Wall St

Simply Wall St

Agenus regains NASDAQ compliance with bid price rule - Investing.com Australia

Investing.com Australia

Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement - Elk Valley Times

Elk Valley Times

Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement - Business Wire

Business Wire

Time Is Running Out For Agenus To Raise Cash (NASDAQ:AGEN) - Seeking Alpha

Seeking Alpha

Up 40%: Is This Red-Hot Growth Stock Still a Buy?

The Motley Fool

Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting - Business Wire

Business Wire

Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting - Business Wire

Business Wire